SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.00+8.5%Dec 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (1613)9/13/2000 12:54:36 PM
From: Mike McFarland  Read Replies (1) of 52153
 
<paradigm like shifts in technology>

rkrw--Have you done well with Gilder picks?
If he goes for the MLNM CRA HGSI types of stocks that
can only contribute to the 'gorilla game' perception
out there. It makes me wonder what the future holds
for second tier players, like GLGC, CRGN, GENXY or even
INCY. Will there be some mergers I wonder, or does
this bioinformatics area get even more competitive.

__________________________________________
For fun I ran "paradigm shift technology biotechnology"
through the googleizer, when precisely did the shift
occur, ha ha--what an overused phrase.

June 1996, The Scientist
"We're going to be inundated by a flood of genomics data," predicts Frank Tally, research director at Cubist Pharmaceuticals, a private company in Cambridge, Mass. To determine relevant genes from those data, an investigator must be well-versed in assay development and genomics, he says.
the-scientist.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext